Magnetic Particle Imaging (MPI): Advancing Molecular Imaging to Enable Breakthrough Research
Systemically track injected labeled immune cells and other cells, in vivo over time. Track macrophages, monocytes, dendritic cells, NK cells, MDSCs and T cells.
Image inflammation, vascularity, nanoparticle-based drug delivery, and brain injury.
Image the accumulation of labeled macrophages in sites of inflammation associated with cancer, arthritis, multiple sclerosis, and tissue damage.
Use magnetic nanoparticles and magnetic particle imaging to produce targeted, localized hyperthermia, for heat-sensitive drug delivery, nanoparticle development and immunogenic stimulation.
Test the relaxation properties of novel magnetic nanoparticles for magnetic particle imaging, heat-sensitive drug delivery, activatable particles, and other therapies.
Latest News, Events and Publications
Advancing Molecular Imaging
Magnetic Insight, leader in Magnetic Particle Imaging (MPI) represents one of the most powerful approaches to preclinical imaging in the last 20 years with translation to the clinic. MPI harnesses nanotechnology in imaging and therapy with a direct bridge to the complete cell therapy workflow and development.
Support for this technology was realized through funding programs from the Brain Initiative, California Institute for Regenerative Medicine (CIRM), the National Institutes of Health (NIH), the Keck foundation, and a University Discovery grant, jointly supported by General Electric, the State of California, and Investors.